Rocuronium Bromide Injection
Product Images NDC 67457-228
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 67457-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide Injection By Age Group (median, 25th And 75th Percentile, And Individual Values) (E7d54155 493b 4cf1 B716 29605150b9e6 03)
Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Injection Maintenance Doses, By Dose (E7d54155 493b 4cf1 B716 29605150b9e6 04)
Rocuronium Bromide Injection 50 mg/5 mL Carton Label (Image 01)
This is a warning label for an injection of Rocuronium Bromide, a paralyzing agent that can cause respiratory arrest, which requires immediate access to artificial respiration facilities. The solution is non-pyrogenic Sterile. Each mL contains 10 mg of Rocuronium Bromide and 2mg of Sodium Acetate. The pH is adjusted to 4 with acetic acid and/or Sodium Hydroxide. This solution must be stored refrigerated between 2 to 8 °C (36 to 46 °F). DO NOT FREEZE. Shelf life is 60 days at room temperature after removal from refrigeration or 30 days after opening. The label provides additional information about dosage, manufacturer's information, and product identifiers.*
Rocuronium Bromide Structural Formula (Image 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.